科济药业-b(02171)再涨超8%,截至发稿,涨6.65%,报23.25港元,成交额6984.85万港元。消息面上,科济药业公布,旗下靶向GPRC5D的自体CAR-T细胞产品CT071,用于治疗新诊断多发性骨髓瘤的研究者发起的临床试验研究结果,已于第30届欧洲血液学协会年会上发布。CT071是一款科济药业基于CARcelerateTM专有平台开发的靶向GPRC5D的CAR-T细胞治疗候选产品,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.